Yo
Accessible I get in this AI
which book you use for medicine
Rheumatic heart disease everything want for exam
| Feature | Details |
|---|---|
| Age of RF | 5-15 years (children & adolescents) |
| Peak RHD prevalence | 3rd and 4th decades of life |
| Sex | RF: equal in both sexes; RHD: more common and more severe in females |
| India prevalence | 5-7 per 1,000 in 5-15 year age group; ~1 million RHD cases |
| India hospital burden | RHD = 20-30% of all CVD hospital admissions |
| Worldwide | >15 million cases; 282,000 new cases/year |
| Risk of RF after GAS pharyngitis | 0.3% to 3% |

| Valve | Involvement |
|---|---|
| Mitral | Nearly 100%; isolated in ~2/3 of cases |
| Aortic | 20-30%; combined with mitral in ~25% |
| Tricuspid | Histologic disease in 15-40%; rarely clinically relevant |
| Pulmonary | Rarely affected |
| Manifestation | Frequency | Notes |
|---|---|---|
| Fever | >90% | Lasts ~12 weeks, tendency to recur |
| Polyarthritis | 75-90% | MOST common; large joints (knees, ankles, elbows, wrists); migratory; NO residual damage; sterile synovial fluid |
| Carditis | 60-70% | Pancarditis; first-degree AV block (most common ECG finding) |
| Sydenham Chorea | 30% | "St. Vitus dance"; involuntary, non-rhythmic purposeless movements; worse on one side; stops during sleep; no residual damage |
| Subcutaneous nodules | <10% | Small (0.5-2 cm), painless, over bony prominences/extensor tendons; appear ~4 weeks after onset |
| Erythema marginatum | <10% | Pink, non-pruritic, blanching macules/papules; serpiginous pattern; trunk and proximal limbs |
| Low-Risk Populations | Moderate/High-Risk Populations |
|---|---|
| Carditis (clinical and/or subclinical echocardiographic valvulitis) | Same |
| Arthritis - polyarticular only | Arthritis - mono OR polyarticular |
| Chorea | Chorea |
| Erythema marginatum | Erythema marginatum |
| Subcutaneous nodules | Subcutaneous nodules |
| Low-Risk | Moderate/High-Risk |
|---|---|
| Polyarthralgia | Monoarthralgia |
| Fever ≥38.5°C | Fever ≥38.5°C |
| ESR ≥60 mm/hr AND/OR CRP ≥3.0 mg/dL | ESR ≥30 mm/hr AND/OR CRP ≥3.0 mg/dL |
| Prolonged PR interval | Prolonged PR interval |
| Treatment | Details |
|---|---|
| Hospitalization | All patients with acute RF |
| Eradication of GAS | IM Benzathine Penicillin G 1.2 million units (single dose) |
| Arthritis | Aspirin 80-100 mg/kg/day (max 4-8 g/day) OR Naproxen 10-20 mg/kg/day |
| NSAID duration | 1-2 weeks until all symptoms resolve |
| Carditis/Heart failure | Diuretics, ARBs, fluid restriction, bed rest; glucocorticoids in severe cases |
| Chorea | Usually self-limiting; resolves in weeks to months |
| Valve surgery | Rarely for acute RF; helpful if acute valve leaflet rupture |
| Weight | Dose |
|---|---|
| >27 kg (>60 lbs) | 1.2 million units IM |
| <27 kg (<60 lbs) | 600,000 units IM |
| Category | Duration |
|---|---|
| RF without carditis | At least 5 years OR until age 18, whichever is longer |
| RF with mild carditis (mild MR or healed carditis) | 10 years after last attack OR until age 25, whichever is longer |
| Severe valvular disease / post-valve surgery | Life-long |
| Fact | Answer |
|---|---|
| Most common cause of mitral stenosis worldwide | RHD |
| Most common valve affected in RHD | Mitral (nearly 100%) |
| Most common valvular pathology in RHD | Mitral regurgitation |
| Pathognomonic lesion of RF | Aschoff body |
| Cell in Aschoff body | Anitschkow cell (caterpillar cell) |
| Mechanism of RF | Molecular mimicry |
| Most common clinical feature | Polyarthritis (75-90%) |
| Only permanent damage in RF | Carditis |
| Most common ECG finding | Prolonged PR interval (1st degree AV block) |
| Drug of choice prophylaxis | Benzathine Penicillin G |
| Most effective route | IM (better than oral) |
| Chorea stops during | Sleep |
| Verrucae size | 1-2 mm |
| MacCallum plaques location | Left atrium |
| Juvenile mitral stenosis | Seen in India - early, severe, with PAH |